Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference46 articles.
1. Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017;Gillessen;Eur Urol,2018
2. EAU–ESTRO–SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer;Cornford;Eur Urol,2017
3. German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients;Rahbar;J Nucl Med,2017
4. PSMA-based radioligand therapy for metastatic castration-resistant prostate cancer: the Bad Berka Experience since 2013;Kulkarni;J Nucl Med,2016
5. Prostate-specific membrane antigen theranostics: therapy with lutetium-177;Ferdinandus;Curr Opin Urol,2018
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand?;Bioengineering;2024-07-14
2. Advances in Radioligand Theranostics in Oncology;Molecular Diagnosis & Therapy;2024-03-31
3. Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study;BMC Cancer;2024-01-29
4. Prognostic Value of PSMA PET/CT in Prostate Cancer;Seminars in Nuclear Medicine;2024-01
5. Therapy of Castration-Resistant Prostate Cancer: Where Is the Place of 225Ac-PSMA?;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3